Digital endpoints in clinical trials of Alzheimer’s disease and other neurodegenerative diseases: challenges and opportunities

Alzheimer’s disease (AD) and other neurodegenerative diseases such as Parkinson’s disease (PD) and Huntington’s disease (HD) are associated with progressive cognitive, motor, affective and consequently functional decline considerably affecting Activities of Daily Living (ADL) and quality of life. St...

Descripción completa

Detalles Bibliográficos
Autores principales: Brem, Anna-Katharine, Kuruppu, Sajini, de Boer, Casper, Muurling, Marijn, Diaz-Ponce, Ana, Gove, Dianne, Curcic, Jelena, Pilotto, Andrea, Ng, Wan-Fai, Cummins, Nicholas, Malzbender, Kristina, Nies, Vera J. M., Erdemli, Gul, Graeber, Johanna, Narayan, Vaibhav A., Rochester, Lynn, Maetzler, Walter, Aarsland, Dag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332162/
https://www.ncbi.nlm.nih.gov/pubmed/37435159
http://dx.doi.org/10.3389/fneur.2023.1210974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332162/
https://www.ncbi.nlm.nih.gov/pubmed/37435159
http://dx.doi.org/10.3389/fneur.2023.1210974

Ejemplares similares